Chemists from ETH Zurich have found a way to produce poorly soluble proteins by caging a uniquely reactive boron compound. This method opens up new possibilities for the synthesis of tailored protein ...

Current treatments for corneal neovascularization rely on invasive intravitreal injections, which limit patient compliance and carry significant risks. To address this, researchers developed a ...